Table 2.
Superficial | Deep | ||||
---|---|---|---|---|---|
Group | MyHC-IIa | MyHC-IIb | MyHC-I | MyHC-IIa | MyHC-IIb |
CA2 | 1455±198 | 3614±510 | 1755±228 | 2127±204 | 4048±365 |
CA2IBU | 1476±229 | 3440±418 | 1653±228 | 2018±367 | 3807±925 |
EX2 | 1611±166 | 3848±547 | 1769±190 | 2220±196 | 4056±617 |
EX2IBU | 1499±172 | a2985±342 | 2101±475 | 2459±619 | 3475±753 |
CA8 | 1845±180 | 4225±485 | 2069±333 | 2783±481 | 4552±658 |
CA8IBU | b1585±191 | 4048±495 | 2105±442 | 2600±531 | 4441±512 |
EX8 | 1890±304 | 4669±415 | 2083±357 | 2720±291 | 5088±349 |
EX8IBU | 1824±211 | 4333±751 | 2029±472 | 2613±606 | 4685±1275 |
Superficial and deep regions of the supraspinatus muscle were analyzed separately for fiber type cross-sectional area. The superficial region had no MyHC-I staining. (n=5–9 at 2 weeks, n=6–7 at 8 weeks) Mean ± StDev, superscript indicates ibuprofen had a significant effect (p<0.05) compared to corresponding non-drug treated group:
p=0.003,
p=0.02